The Contagion® Influenza specialty page provides influenza-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
The tech mogul shares that world leaders need to prepare for the next pandemic—whatever the root cause—including plans for mobilizing military, health, and other resources while coordinating efforts with private industry.
Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.
With influenza B making a late-season rise, health officials are warning that B viruses may cause a second wave of flu this season, while the FDA is backing some alternatives to egg-based flu vaccines.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512